| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q7ZXR9 | MGC53199 protein; | NULL | NP_001079555.1; | 303 | clawed frog |
| Q8UW98 | Galectin; | lgals9c; xgalectin-IIIa; | NP_001082202.1; | 343 | clawed frog |
| Q90ZT5 | Sprouty2delta; | NULL | NP_001082112.1; | 307 | clawed frog |
| Q91522 | Nuclear factor 1; | NULL | NULL | 433 | clawed frog |
| Q91623 | Nkx-related protein; | nkx2-3; XNkx-2.3; | NP_001081667.1; | 335 | clawed frog |
| Q8AVN2 | Snrp116-pending-prov protein; | NULL | NP_001080281.1; | 974 | clawed frog |
| Q98UE1 | Collagen alpha2(IV; Fragment; | NULL | NULL | 116 | clawed frog |
| A1A5J8 | Smarcd1 protein; | smarcd1; Smarcd1; | NP_001136258.1; | 507 | clawed frog |
| A1L2I3 | LOC100036856 protein; | btn2a2; LOC100036856; | NP_001090611.1; | 309 | clawed frog |
| A1L2L7 | LOC100036886 protein; Fragment; | LOC100036886; | NULL | 295 | clawed frog |
| A2RVA2 | LOC100037154 protein; Fragment; | LOC100037154; | NULL | 222 | clawed frog |
| A1L2U6 | LOC100036957 protein; | trub2; LOC100036957; | NP_001091191.1; | 329 | clawed frog |
| A1L2T3 | LOC100036944 protein; | krt5.6; LOC100036944; | NP_001091183.1; | 591 | clawed frog |
| A5D8P1 | Uncharacterized protein; | hsd17b14; | NP_001128543.1; | 277 | clawed frog |
| A2VDC8 | LOC100037221 protein; Fragment; | LOC100037221; | NULL | 351 | clawed frog |
| Q08AX2 | LOC100158395 protein; | serpinh1; LOC100158395; | NP_001121311.1; | 467 | clawed frog |
| A5PKN2 | LOC100101285 protein; Fragment; | LOC100101285; | NULL | 595 | clawed frog |
| A5PKQ3 | LOC100101302 protein; | clk3; LOC100101302; | NP_001093358.1; | 497 | clawed frog |
| Q08AV4 | Lbr-A protein; | lbr-A; | NULL | 620 | clawed frog |
| A5Y827 | MHC class II antigen beta chain; Fragment; | NULL | NULL | 52 | clawed frog |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |